Literature DB >> 31414350

Plasma CXCL10 correlates with HAND in HIV-infected women.

R Burlacu1, A Umlauf2, T D Marcotte2, B Soontornniyomkij2, C C Diaconu3, A Bulacu-Talnariu4, A Temereanca5,6, S M Ruta5,6, S Letendre2, L Ene4, C L Achim2.   

Abstract

HIV-associated neurocognitive disorder (HAND) is characterized by chronic immune activation. We aimed to identify biomarkers associated with HAND and to investigate their association with cognitive function and sex, in a homogenous cohort of HIV-infected (HIV+) young adults, parenterally infected during early childhood. One hundred forty-four HIV+ Romanian participants (51% women) without major confounders underwent standardized neurocognitive and medical evaluation in a cross-sectional study. IFN-γ, IL-1β, IL-6, CCL2, CXCL8, CXCL10, and TNF-α were measured in plasma in all participants and in cerebrospinal fluid (CSF) in a subgroup of 56 study participants. Biomarkers were compared with neurocognitive outcomes, and the influence of sex and HIV disease biomarkers was assessed. In this cohort of young adults (median age of 24 years), the rate of neurocognitive impairment (NCI) was 36.1%. Median current CD4+ count was 479 cells/mm3 and 36.8% had detectable plasma viral load. Women had better HIV-associated overall status. In plasma, controlling for sex, higher levels of IL-6 and TNF-α were associated with NCI (p < 0.05). Plasma CXCL10 showed a significant interaction with sex (p = 0.02); higher values were associated with NCI in women only (p = 0.02). Individuals with undetectable viral load had significantly lower plasma CXCL10 (p < 0.001) and CCL2 (p = 0.02) levels, and CSF CXCL10 (p = 0.01), IL-6 (p = 0.04), and TNF-α (p = 0.04) levels. NCI in young men and women living with HIV was associated with higher IL-6 and TNF-α in plasma, but not in the CSF. CXCL10 was identified as a biomarker of NCI specifically in women with chronic HIV infection.

Entities:  

Keywords:  CXCL-10; HIV inflammation; HIV women; Neurocognitive; Young adults

Mesh:

Substances:

Year:  2019        PMID: 31414350      PMCID: PMC7018596          DOI: 10.1007/s13365-019-00785-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  51 in total

Review 1.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Viral Load and Neuropsychological Functioning in HIV Seropositive Individuals:A Preliminary Descriptive Study.

Authors:  K Robertson; S Fiscus; J Wilkins; C van der Horst; C Hall
Journal:  J NeuroAIDS       Date:  1996

Review 3.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

4.  Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Authors:  P Morlat; P Parneix; D Douard; D Lacoste; M Dupon; G Chêne; J L Pellegrin; J M Ragnaud; F Dabis
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

5.  Chemokines and receptors in HIV encephalitis.

Authors:  V J Sanders; C A Pittman; M G White; G Wang; C A Wiley; C L Achim
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

6.  HIV-1 diversity in Romania.

Authors:  C Apetrei; A Necula; C Holm-Hansen; I Loussert-Ajaka; I Pandrea; C Cozmei; A Streinu-Cercel; F R Pascu; E Negut; G Molnar; M Duca; M Pecec; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

7.  Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.

Authors:  Ana Canestri; François-Xavier Lescure; Stephane Jaureguiberry; Antoine Moulignier; Corinne Amiel; Anne Geneviève Marcelin; Gilles Peytavin; Roland Tubiana; Gilles Pialoux; Christine Katlama
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

8.  The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection.

Authors:  Sven Hagen; Marcus Altfeld
Journal:  J Virus Erad       Date:  2016-04-01

9.  Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.

Authors:  Linda Chang; Thomas Ernst; Coryse St Hillaire; Katherine Conant
Journal:  Antivir Ther       Date:  2004-06

10.  HIV- and AIDS-associated neurocognitive functioning in Zambia - a perspective based on differences between the genders.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-11       Impact factor: 2.570

View more
  12 in total

Review 1.  Cytokines and chemokines involved in the defense reaction against HIV-1 and hepatitis B virus: isn't it time to use a standardized nomenclature of the involved mediators?

Authors:  Lutz G Gürtler
Journal:  Virus Genes       Date:  2019-12-17       Impact factor: 2.332

Review 2.  Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era.

Authors:  Albert M Anderson; Qing Ma; Scott L Letendre; Jennifer Iudicello
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-15       Impact factor: 5.071

3.  HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment.

Authors:  Vurayai Ruhanya; Graeme Brendon Jacobs; Robert H Paul; John A Joska; Soraya Seedat; George Nyandoro; Richard H Glashoff; Susan Engelbrecht
Journal:  J Neurovirol       Date:  2022-04-08       Impact factor: 3.739

4.  Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.

Authors:  Naomi Swanta; Subhash Aryal; Vicki Nejtek; Sangeeta Shenoy; Anuja Ghorpade; Kathleen Borgmann
Journal:  J Neurovirol       Date:  2020-03-19       Impact factor: 2.643

5.  Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.

Authors:  Magnus Gisslen; Sheila M Keating; Serena Spudich; Victor Arechiga; Sophie Stephenson; Henrik Zetterberg; Clara Di Germanio; Kaj Blennow; Dietmar Fuchs; Lars Hagberg; Philip J Norris; Julia Peterson; Barbara L Shacklett; Constantin T Yiannoutsos; Richard W Price
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

6.  An Exploratory Study of Correlates of Allostatic Load in Older People Living With HIV.

Authors:  Pariya L Fazeli; Drenna Waldrop-Valverde; Ibrahim Yigit; Bulent Turan; Jeff Edberg; Mirjam Kempf; David Vance
Journal:  J Acquir Immune Defic Syndr       Date:  2020-04-15       Impact factor: 3.771

7.  Effects of Morphine on Gp120-induced Neuroinflammation Under Immunocompetent Vs. Immunodeficient Conditions.

Authors:  Dalton Canonico; Sadie Casale; Tristan Look; Ling Cao
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-21       Impact factor: 7.285

Review 8.  Nef-induced CCL2 Expression Contributes to HIV/SIV Brain Invasion and Neuronal Dysfunction.

Authors:  Michael H Lehmann; Jonas M Lehmann; Volker Erfle
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

Review 9.  Cannabis and Inflammation in HIV: A Review of Human and Animal Studies.

Authors:  Ronald J Ellis; Natalie Wilson; Scott Peterson
Journal:  Viruses       Date:  2021-08-02       Impact factor: 5.048

10.  Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV.

Authors:  C Wei-Ming Watson; Laura M Campbell; Ni Sun-Suslow; Suzi Hong; Anya Umlauf; Ronald J Ellis; Jennifer E Iudicello; Scott Letendre; Thomas D Marcotte; Robert K Heaton; Erin E Morgan; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2021-07       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.